Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × S-Adenosylmethionine × Clear all
NCT05701553 2023-02-02

Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Unknown
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03178929 2017-06-07

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

Beijing Insight Science & Technology Co. Ltd.

Phase NA Unknown
207 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02586285 2016-04-01

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 1 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡